Growth Metrics

ProQR Therapeutics (PRQR) Asset Utilization Ratio (2021 - 2023)

Historic Asset Utilization Ratio for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2023 value amounting to 0.05.

  • ProQR Therapeutics' Asset Utilization Ratio rose 8117.6% to 0.05 in Q4 2023 from the same period last year, while for Dec 2023 it was 0.05, marking a year-over-year increase of 8117.6%. This contributed to the annual value of 0.12 for FY2024, which is 18424.74% up from last year.
  • ProQR Therapeutics' Asset Utilization Ratio amounted to 0.05 in Q4 2023, which was up 8117.6% from 0.03 recorded in Q3 2023.
  • In the past 5 years, ProQR Therapeutics' Asset Utilization Ratio registered a high of 0.05 during Q4 2023, and its lowest value of 0.01 during Q4 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.02, with a median of 0.02 in 2022.
  • Per our database at Business Quant, ProQR Therapeutics' Asset Utilization Ratio soared by 24170.3% in 2022 and then skyrocketed by 2259.73% in 2023.
  • Over the past 3 years, ProQR Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 241.7% to 0.03 in 2022, then surged by 81.18% to 0.05 in 2023.
  • Its Asset Utilization Ratio stands at 0.05 for Q4 2023, versus 0.03 for Q3 2023 and 0.02 for Q2 2023.